Keros Therapeutics (KROS)
(Real Time Quote from BATS)
$56.34 USD
+1.15 (2.08%)
Updated Apr 24, 2024 02:34 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.31 | 2.29% |
Earnings Summary
For their last quarter, Keros Therapeutics (KROS) reported earnings of -$1.34 per share, beating the Zacks Consensus Estimate of $-1.38 per share. This reflects a positive earnings surprise of 2.90%. Look out for KROS's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.31 per share, reflecting a year-over-year decrease of 3.97%.
Earnings History
Price & Consensus
Zacks News for KROS
Does Keros Therapeutics, Inc. (KROS) Have the Potential to Rally 35.66% as Wall Street Analysts Expect?
KROS: What are Zacks experts saying now?
Zacks Private Portfolio Services